Letters to the Editor
IL-17A as potential novel biomarker and promising therapeutic target in Kawasaki disease patients
M.V. Mastrolia1, E. Ferraro2, E. Marrani3, L. Gatti4, M. Moriondo5, G. Simonini6
- Rheumatology Unit, ERN ReCONNET Center, Meyer Children’s Hospital IRCCS, Firenze; and Neurofarba Department, University of Florence, Italy. maria.mastrolia@unifi.it
- Laboratory of Immunology and Molecular Microbiology, Meyer Children's Hospital IRCCS, Florence, Italy.
- Rheumatology Unit, ERN ReCONNET Center, Meyer Children’s Hospital IRCCS, Firenze, Italy.
- Rheumatology Unit, ERN ReCONNET Center, Meyer Children’s Hospital IRCCS, Firenze, Italy.
- Laboratory of Immunology and Molecular Microbiology, Meyer Children's Hospital IRCCS, Florence, Italy.
- Rheumatology Unit, ERN ReCONNET Center, Meyer Children’s Hospital IRCCS, Firenze; and Neurofarba Department, University of Florence, Italy.
CER17969
2025 Vol.43, N°4
PI 0766
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 40201968 [PubMed]
Received: 04/07/2024
Accepted : 19/07/2024
In Press: 08/04/2025
Published: 08/04/2025
